Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
MicroRNAs01:22

MicroRNAs

3.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Subclinical brainstem encephalitis in Ramsay Hunt syndrome: a case of radiological-clinical dissociation.

Neurologia i neurochirurgia polska·2026
Same author

Exosomes in Myasthenia Gravis-Review.

Cells·2026
Same author

Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Annals of neurology·2026
Same author

A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis.

Therapeutic advances in neurological disorders·2026
Same author

Female-enriched <i>Eggerthella lenta</i> drives neuroinflammation and IFN-γ via host receptor TLR2.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Dec 30, 2025

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

15.8K

microRNA and exosome profiling in multiple sclerosis.

Marcin P Mycko1, Sergio E Baranzini2

  • 1Department of Neurology, Laboratory of Neuroimmunology, Faculty of Medicine, University of Warmia and Mazury, Olsztyn, Poland.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 23, 2020
PubMed
Summary

Non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), and exosomes are crucial in autoimmune demyelination. Their roles in immune responses and myelination make them promising biomarkers and therapeutic targets for multiple sclerosis (MS).

Keywords:
EAEbiomarkerexosomeimmune responsemicroRNAmultiple sclerosis

More Related Videos

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.9K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.7K

Related Experiment Videos

Last Updated: Dec 30, 2025

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

15.8K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.9K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.7K

Area of Science:

  • Biochemistry
  • Immunology
  • Neuroscience

Background:

  • Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), are key regulators of cellular processes, challenging the notion of
  • junk
  • dark
  • RNA.
  • MicroRNAs (miRNAs) and exosomes are increasingly recognized for their roles in autoimmune demyelination and immune signaling.

Purpose of the Study:

  • To review recent advances in microRNA (miRNA) and exosome profiling in multiple sclerosis (MS) and experimental models.
  • To highlight the potential of miRNAs and exosomes as biomarkers and therapeutic targets for MS.

Main Methods:

  • Literature review of studies on miRNA and exosome profiling in MS.
  • Analysis of experimental models investigating miRNA and exosome functions in demyelination.

Main Results:

  • MicroRNAs (miRNAs) are implicated in regulating immune responses and myelination, critical for multiple sclerosis (MS).
  • Exosomes play roles in immune signaling, inflammation, and angiogenesis, with potential for therapeutic delivery and biomarker applications in MS.

Conclusions:

  • MicroRNA (miRNA) and exosome profiling offer promising avenues for understanding and treating multiple sclerosis (MS).
  • These molecules represent valuable candidates for both diagnostic biomarkers and therapeutic strategies in MS management.